ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate

Benzinga Newsdesk www.benzinga.com Negative 96.9%

Neg 96.9% Neu 0% Pos 0%

ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.